Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6248.01 | 1445 / 1445 | 100% | 109.69 | 183 / 183 |
lung | 100% | 9322.83 | 578 / 578 | 100% | 123.88 | 1155 / 1155 |
ovary | 100% | 6238.89 | 180 / 180 | 100% | 106.74 | 430 / 430 |
pancreas | 100% | 5633.73 | 328 / 328 | 100% | 113.29 | 178 / 178 |
prostate | 100% | 7873.46 | 245 / 245 | 100% | 127.14 | 502 / 502 |
skin | 100% | 7492.86 | 1809 / 1809 | 100% | 155.28 | 472 / 472 |
stomach | 100% | 6356.25 | 359 / 359 | 100% | 142.61 | 286 / 286 |
uterus | 100% | 7268.99 | 170 / 170 | 100% | 122.28 | 459 / 459 |
breast | 100% | 8596.80 | 459 / 459 | 100% | 142.71 | 1117 / 1118 |
thymus | 100% | 8270.83 | 653 / 653 | 100% | 112.40 | 604 / 605 |
bladder | 100% | 6700.86 | 21 / 21 | 100% | 142.06 | 503 / 504 |
kidney | 100% | 6089.78 | 89 / 89 | 100% | 89.93 | 899 / 901 |
liver | 100% | 5065.04 | 226 / 226 | 100% | 79.51 | 405 / 406 |
brain | 100% | 5148.91 | 2634 / 2642 | 100% | 140.62 | 705 / 705 |
adrenal gland | 100% | 9089.17 | 258 / 258 | 100% | 117.06 | 229 / 230 |
intestine | 100% | 6759.65 | 966 / 966 | 99% | 146.17 | 524 / 527 |
adipose | 100% | 8371.69 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 113.45 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 104.89 | 29 / 29 |
muscle | 100% | 7172.74 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 9647.94 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 123.84 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 50.40 | 1 / 1 |
blood vessel | 100% | 6253.32 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 4473.85 | 854 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 7212.88 | 920 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0016567 | Biological process | protein ubiquitination |
GO_0140627 | Biological process | ubiquitin-dependent protein catabolic process via the C-end degron rule pathway |
GO_0048820 | Biological process | hair follicle maturation |
GO_0070588 | Biological process | calcium ion transmembrane transport |
GO_0080008 | Cellular component | Cul4-RING E3 ubiquitin ligase complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0031464 | Cellular component | Cul4A-RING E3 ubiquitin ligase complex |
GO_1990756 | Molecular function | ubiquitin-like ligase-substrate adaptor activity |
GO_0019902 | Molecular function | phosphatase binding |
GO_0005515 | Molecular function | protein binding |
GO_0005262 | Molecular function | calcium channel activity |
Gene name | TRPC4AP |
Protein name | Short transient receptor potential channel 4-associated protein (Trp4-associated protein) (Trpc4-associated protein) (Protein TAP1) (TNF-receptor ubiquitous scaffolding/signaling protein) (Protein TRUSS) Alternative protein TRPC4AP |
Synonyms | C20orf188 TRRP4AP |
Description | FUNCTION: Substrate-recognition component of a DCX (DDB1-CUL4-X-box) E3 ubiquitin-protein ligase complex required for cell cycle control . The DCX(TRPC4AP) complex specifically mediates the polyubiquitination and subsequent degradation of MYC as part of the DesCEND (destruction via C-end degrons) pathway . The DesCEND (destruction via C-end degrons) pathway recognizes a C-degron located at the extreme C terminus of target proteins, leading to their ubiquitination and degradation . The DCX(TRPC4AP) complex specifically recognizes proteins with an arginine at the minus 3 position (R-3 motif) at the C-terminus, such as MYC, leading to their ubiquitination and degradation . Also participates in the activation of NFKB1 in response to ligation of TNFRSF1A, possibly by linking TNFRSF1A to the IKK signalosome (By similarity). Involved in JNK activation via its interaction with TRAF2 (By similarity). Also involved in elevation of endoplasmic reticulum Ca(2+) storage reduction in response to CHRM1 (By similarity). . |
Accessions | ENST00000451813.6 [Q8TEL6-3] ENST00000252015.3 [Q8TEL6-1] Q8TEL6 L8E890 |